LorettaMarieItriMD

Physician

Dr. Itri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
64 Three Mile Harbor Drive
East Hampton, NY 11937
Phone+1 908-436-7294

PubMed

75 citations
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.
Aditya Bardia, Sara M. Tolaney, Kevin Punie, Delphine Loirat, Mafalda Oliveira
Annals of Oncology. 2021-09-01
270 citations
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Ch...
Scott T. Tagawa, Arjun Vasant Balar, Daniel P. Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot
Journal of Clinical Oncology. 2021-04-30
614 citations
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Aditya Bardia, Sara A. Hurvitz, Sara M Tolaney, Delphine Loirat, Kevin Punie
The New England Journal of Medicine. 2021-04-21

ESMO 2020: Immunomedics Presents New Trodelvy Data in Two IndicationsSeptember 21st, 2020
Immunomedics Appoints Dr. Loretta Itri Chief Medical OfficerFebruary 14th, 2020
Immunomedics Nabs J&J Veteran for CMO as It Presses on with ADC RedoFebruary 14th, 2020
Join now to see all